CliffBio
small molecule

GYNE-LOTRIMIN 3

CLOTRIMAZOLE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameGYNE-LOTRIMIN 3
Active ingredientCLOTRIMAZOLE
Strength2%
Dosage formCREAM
RouteVAGINAL
ModalitySmall molecule
FDA approvalNovember 1998
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.